Prelude Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSI
DM
NCM
WA
SFM
RCMNY
N
Prelude Capital Management's BDSI Position: Q1 2020 in Review
Prelude Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 13,900 shares — an estimated $88K sold.
Prelude Capital Management first reported a position in BDSI in Q4 2013 and held it in 15 quarters. The position peaked at $691K in Q2 2015. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.
- Prelude Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
- Prelude Capital Management sold 13,900 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $88K.
- Prelude Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 15 quarters.
- Prelude Capital Management's BioDelivery Sciences International, Inc. position peaked at $691K in Q2 2015.
- 153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.
Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.